Task Force Breast Cancer
January 19, 2025Task Force Geriatric Oncology
January 19, 2025Introduction
The Cancer Survivorship Task Force was established in April 2012. The first chair was Dr. Evandro de Azambuja, medical director, Br.E.A.S.T. Data Centre, Institut Jules Bordet, Brussels. The members were Drs. Azim Jr, Buisseret, tKint de Roodenbeeke (Institut Jules Bordet, Brussels) and Dr. Langenaeken (AZ KLINA, Brasschaat).
The aim of the Task Force was to develop guidance on issues regarding follow-up of breast cancer patients who have completed their primary treatment. Guidelines were developed with regard to follow-up, both in the general breast cancer population and in high-risk and special populations, fertility issues, cardiac toxicity, bone health, neurocognitive dysfunction, and neurotoxicity of adjuvant treatment. Subsequently the Task Force has embarked on the use of mind-body techniques e.g. Emotional Freedom Techniques (EFT) in cancer-related cognitive impairment and fear of cancer recurrence.
Projects
- [Dr. Debruyne] The EMOTICON trial: A clinical trial set up in 2016 on behalf of the BSMO Survivorship Task Force to determine the efficacy of Emotional Freedom Techniques (EFT) as an intervention strategy to reduce cognitive complaints in cancer survivors. The project was submitted to the Fund Suzanne Duchesne and ‘Kom op tegen Kanker’ joint call for innovative projects regarding psychosocial care in (ex) cancer patients and their caregivers, and approved for funding. The trial was recently published in the new open access journal of The Lancet Group, EClinicalMedicine; the results are very promising. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00361-8/fulltext
- [Dr. Debruyne] Regarding this innovative technique, another project on the use of EFT for Fear of Cancer Recurrence was granted the Pfizer Oncology Award 2020: https://www.pfizerpro.be/sites/default/files/bjmo_article_winner_2020_dr_debruyne.pdf . The project is now in the process of setting up.
- [Dr. Debruyne] The implementation of EFT during and after cancer treatment is the subject of an implementation project approved by the Social Grants 2021 call of the ‘Stichting tegen Kanker’
- Members of the group have participated in the survivorship & rehabilitation working group of the Belgian Cancer Barometer in 2021. https://www.e-cancer.be/nl/projects/belgian-cancer-barometer-2020-bcb2020
https://www.e-cancer.be/fr/projects/belgian-cancer-barometer-2020-bcb2020 - The REMOTE trial: Targeting Fear of Cancer Recurrence in Cancer Survivors: a Multicentre Randomized Controlled Trial to Evaluate Internet-Based Emotional Freedom Techniques and Internet-Based Mindfulness Meditation as Intervention Strategies
Publications
- de Azambuja E, Azim HA, Buisseret L et al: Belgian Society of Medical Oncology (BSMO) Task Force on Breast Cancer Survivorship: Belg J Med Oncol 2013;7(5):142-55)1.
- Tack L, Lefebvre T, Lycke M, et al: A randomised wait-list controlled trial to evaluate Emotional Freedom Techniques for self-reported cancer-related cognitive impairment in cancer survivors (EMOTICON)
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00361-8/fulltext
https://doi.org/10.1016/j.eclinm.2021.101081. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Guidelines
Guidelines have been developed with regard to follow-up, both in the general breast cancer population and in high-risk and special populations, fertility issues, cardiac toxicity, bone health, neurocognitive dysfunction, and neurotoxicity of adjuvant treatment. These guidelines were reported in the Belgian Journal of Medical Oncology (Belg J Med Oncol 2013;7(5):142-55)1.
Contact
Pr. Annie Drowart
| MEMBER | AFFILIATION | |
| Dr. Christine Langenaeken* | AZ KLINA, Brasschaat | Christine.langenaeken@klina.be |
| Dr. Frank Cornelis | Cliniques Universitaires St Luc, UCL | frank.cornelis@uclouvain.be |
| Pr. Annie Droward | Institut Jules Bordet, Brussels | Annie.drowart@bordet.be |
| Pr. Jean Klastersky | Institut Jules Bordet, Brussels | mariealine.echterbille@bordet.be |
| Dr. Christel Fontaine | UZ Brussel, Brussels | Christel.fontaine@uzbrussel.be |
| Dr. Philip Debruyne | AZ Groeninge, Kortrijk | Philip.debruyne@azgroeninge.be |
| Dr. Vincent Verschaeve | GHDC, Charleroi | Vincent.verschaeve@ghdc.be |
| Dr. Florence Van Ryckeghem | AZ Glorieux, Ronse | florence.vanryckeghem@azglorieux.be |
| Pr. Jeroen Mebis | Jessa Ziekenhuis, Hasselt | Heidi.van.den.bulck@imelda.be |
| Dr. Heidi Van den Bulck | Imelda, Bonheiden | Jeroen.mebis@jessa.be |
| Dr. Katherine Vandenborre | AZ Vesalius, Tongeren | Katherine.vandenborre@azvesalius.be |
*Chair
|
ACTIVE COLLABORATOR |
AFFILIATION |
|
|
Laure-Anne Teuwen |
UZ Antwerpen, Antwerpen |
|
|
Kurt Geldhof |
Jan Yperman, Ieper |
|
|
Caroline Lamot |
Vitaz, St Niklaas |
|
|
Tom Boterberg |
UZ Gent, Gent |
|
|
Thaïs Baert |
UZ Leuven, Leuven |
In September 2025, Dr. Langenaeken will retire and her position and mandate as member and Chair of the BSMO Cancer Survivorship Task Force will become available.
We invite all BSMO members with an interest in cancer survivorship to join the BSMO Cancer Survivorship Task Force, and if you feel up to chairing the Task Force, let us know!
Physicians who would like to have more information about the Survivorship Task Force and/or would like to join the group: please contact the chair or a member of the Task Force